AI-generated voice clones are bringing back the voices of people with MND, allowing some to communicate, connect, and even ...

Today the victim of motor neurone disease ... unlucky - the odds were three million to one against this disease hitting me. Only 4,000 people in Britain are currently suffering from this disease ...

Fundraiser Sam Perkins, who raised thousands of pounds to fund research into motor neurone disease (MND), has died. The sportsman raised hundreds of thousands of pounds after being diagnosed with ...

Michelle Grattan does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...

Sam Perkins was a keen triathlete and much of his fundraising was sports based A campaigner and fundraiser for research into motor neurone disease (MND) has died, his family have said. Sam Perkins ...

Otuoma died after a long battle with Motor Neurone Disease (MND ... Primary Lateral Sclerosis (PLS) This condition affects only the upper motor neurons, causing difficulty and slowness in ...

"Motor neurone disease is a beast of a disease -- it doesn't discriminate. It robs you of your ability to move, speak, swallow, and eventually breathe," he said. "But it did something else ...

A campaigner and fundraiser for research into motor neurone disease (MND) has died, his family have said. Sam Perkins, from East Leake, Nottinghamshire, was 37 when he was diagnosed with the ...

Neale Daniher, a campaigner in the fight against motor neurone disease and a former champion Essendon footballer, is the 2025 Australian of the Year, Himself a sufferer from the deadly disease ...

A DAD-of-three recently diagnosed with motor neurone disease is calling for more research funding to help find a cure in the future. Craig Hamilton, who owns an art and tattoo studio in Cleator ...

A new short film documenting the remarkable progress towards a treatment for Motor Neuron Disease (MND), also known as ALS ... The company hopes the therapy will move to human safety trials next year, ...